Creatinine Meter Market

The global creatinine meter market is estimated to project growth at a robust CAGR of around 8% to 9% during the forecast period 2022 to 2032. Among the end use vertical, the point of care use is expected to emerge as a highly remunerative segment, accounting for the sales of total USD 1,250 Mn by the end of 2032. The demand for creatinine meters across the point of care segment are anticipated to reach USD 650 Mn by 2022, accelerating at a CAGR of 7% to 8% between 2022 and 2032.

Report Attribute Details
Creatinine Meter Market Projected Growth Rate (2022 to 2032) 8% to 9% CAGR
Expected Value Creatinine Meter in Point of Care Segment (2022) USD 650 Million
Anticipated Value Creatinine Meter in Point of Care Segment (2032) USD 1,250 Million
Projected Growth Rate of Point of Care Segment (2022 to 2032) 7% to 8% CAGR

Creatinine meters are medical devices that are primarily used for the diagnosis and treatment of chronic kidney diseases such as glomerulonephritis, kidney stones, polycystic kidney disease, and chronic intrinsic kidney failures among others. They are used for measuring the blood creatinine level in patients suffering from kidney and renal disorders.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Which are Some Prominent Drivers Spearheading Creatinine Meter Market Growth

Commonly, it takes several hours to test creatinine at clinical labs. In addition to this, risk of patients with specific conditions is high in the clinical testing due to the use of imaging agents like iodine and barium, which are generally used in radiological procedures.

On the other hand, creatinine meters allow healthcare professionals to get the precise quantitative results for creatinine tests within minutes with ease of use. On account of this, a swift inclination towards adopting creatinine meters, particularly handheld devices, is being witnessed across the healthcare sector worldwide for the testing of kidney and renal disorders, bolstering the demand in the global market.

What are the Challenges Faced by the Creatinine Meter Market

Although there are several advantages associated with the use of creatinine meters, high cost of these equipments, specifically handheld creatinine meters, and need for skilled professionals for assessing the ratings are hindering the sales in the global market. In addition to this, availability of low-cost creatinine testing solutions and equipments is further hampering the demand for creatinine meters in the market.

Nikhil Kaitwade
Nikhil Kaitwade

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Why is North America Emerging as an Opportunistic Creatinine Meter Market

As per FMI North America is forecast to emerge as the most lucrative market for creatinine meter between 2022 and 2032.

Demand for creatinine meters is increasing at a rapid pace across the medical sector, due to the increasing usage in renal dialysis monitoring and measurement of blood and urine analytes. Thus, leading players in the market are focusing on launching novel products to cater to this growing demand.

For instance, in 2022, Nova Biomedical, a U.S.-based manufacturer of medical diagnostics equipment announced launching a new easy-to-use meter creatinine, Nova Max Pro Creatinine/eGFR Meter System, capable of early detection of kidney disease and kidney function screening in point-of-care settings. A slew of such new product launches is estimated to augment the sales in the North America market.

How is Europe Contributing to the Growth of the Creatinine Meter Market

Future Market Insights states that Europe is anticipated to exhibit rapid growth in the global creatinine meter market during the forecast period 2022-2032.

The burden of chronic kidney diseases and renal disorders is rapidly increasing across Europe, owing to changing eating habits, rising obesity, and smoking. According to a study by the Kidney Care Organization, nearly 10% of the U.K population, or more than 6.5 Mn people in the country are estimated to be suffering from chronic kidney diseases.

As creatinine meters are extensively used in the diagnosis and treatment of these diseases, growing prevalence of chronic kidney diseases is projected to propel the demand in the Europe market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Market Competition

Some of the leading players in the creatinine meter market are Thermo Fisher Scientific, Hitachi, Siemens Healthcare GmbH, Randox Laboratories, Abbott, Nova Biomedical, Pointe Scientific, Diasys Diagnostic Systems GmbH, Sentinel Ch. Spa., and others.

Prominent players in the global creatinine meter market are aiming at introducing novel potable and easy-to-use products for point of care use to gain edge in the highly competitive market.

Scope of Report

Report Attribute Details
Growth Rate CAGR of 8% to 9% from 2022 to 2032
Base Year for Estimation 2021
Historical Data 2015 to 2020
Forecast Period 2022 to 2032
Quantitative Units Revenue in USD Million, Volume in Kilotons and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered Product, Modularity, End Use, Region
Countries Covered North America; Latin America; Europe; CIS & Russia; APEJ; Japan; Middle East and Africa
Key Companies Profiled Thermo Fisher Scientific; Hitachi; Siemens Healthcare GmbH; Randox Laboratories; Abbott; Nova Biomedical; Pointe Scientific; Diasys Diagnostic Systems GmbH; Sentinel Ch. Spa.; Others
Customization Available Upon Request

Key Segments Profiled in the Creatinine Meter Market Survey

By Product:

  • Creatinine Meters
  • Reagents
  • Sensor Strips & Kits

By Modularity:

  • Handheld
  • Desktop

By End Use:

  • Point of Care Use
  • Hospitals
  • Diagnostic Laboratories
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • CIS & Russia
  • APEJ
  • Japan
  • Middle East and Africa

Frequently Asked Questions

What is the sales forecast for creatinine meter in the global market until 2032?

FMI projects the sales of creatinine meter in the market is expected to rise at 8% to 9% value CAGR by 2032

Which region is forecast to be the most lucrative for creatinine meter market growth?

The global creatinine meter market is expected to be dominated by North America over the forecast period 2022-2032.

Which are some leading creatinine meter manufacturers?

Thermo Fisher Scientific, Hitachi, Siemens Healthcare GmbH, Randox Laboratories, Abbott, Nova Biomedical, Pointe Scientific, Diasys Diagnostic Systems GmbH, Sentinel Ch. Spa., and others are some of the leading players in the prominent creatinine meter market.

Table of Content
	1. Executive Summary
	2. Industry Introduction, including Taxonomy and Market Definition
	3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
	4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
	5. Pricing Analysis
	6. Global Market Analysis and Forecast
		6.1. By Product
		6.2. By Modularity
		6.3. By End Use
	7. Global Market Analysis and Forecast, By Product
		7.1. Creatinine Meters
		7.2. Reagents
		7.3. Sensor Strips & Kits
	8. Global Market Analysis and Forecast, By Modularity
		8.1. Handheld
		8.2. Desktop
	9. Global Market Analysis and Forecast, By End Use
		9.1. Point of Care Use
		9.2. Hospitals
		9.3. Diagnostic Laboratories
		9.4. Others
	10. Global Market Analysis and Forecast, By Region
		10.1. North America
		10.2. Latin America
		10.3. Europe
		10.4. CIS & Russia
		10.5. APEJ
		10.6. Japan
		10.7. Middle East and Africa
	11. North America Sales Analysis and Forecast, by Key Segments and Countries
	12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
	13. Europe Sales Analysis and Forecast, by Key Segments and Countries
	14. CIS & Russia Sales Analysis and Forecast, by Key Segments and Countries
	15. APEJ Sales Analysis and Forecast, by Key Segments and Countries
	16. Japan Sales Analysis and Forecast, by Key Segments and Countries
	17. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries
	18. Sales Forecast by Product, Modularity, and End Use for 30 Countries
	19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
	20. Company Profile
		20.1. Thermo Fisher Scientific
		20.2. Hitachi
		20.3. Siemens Healthcare GmbH
		20.4. Randox Laboratories
		20.5. Abbott
		20.6. Nova Biomedica
		20.7. Pointe Scientific
		20.8. Diasys Diagnostic Systems GmbH
		20.9. Sentinel Ch. Spa

Explore Testing Equipment Insights

View Reports
Future Market Insights

Creatinine Meter Market

Schedule a Call